Mela M	66069
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma.